Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

RetroSense Therapeutics
330 East Liberty Street, LL
Ann Arbor, MI 48104
Phone: 734-369-9333
www.retro-sense.com

RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) and advanced dry age-related macular degeneration (advanced dry-AMD). There are currently no FDA approved drugs to improve or restore vision in patients with these retinal degenerative conditions. The Company's approach to using optogenetics in vision restoration is based on pioneering, proprietary research conducted at Wayne State University and Massachusetts General Hospital. RetroSense has worldwide exclusive rights to the relevant intellectual property from both institutions. RetroSense is led by a team of seasoned veterans with deep experience in taking products from the discovery stage through to the clinic.

Key Contact
Name
Sean Ainsworth
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/12/15 $6,000,000 Series A Blue Water Angels
Michigan Economic Development Corp.
Nerveda
SDL Capital
Tech Coast Angels
undisclosed
11/13/15 $6,000,000 Series B Blue Water Angels
ExSight Capital
RBV Capital
Santen Pharmaceuticals
undisclosed